Bank of New York Mellon’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Sell
133,906
-2,416
-2% -$23.9K ﹤0.01% 3207
2026
Q1
$1.33M Buy
136,322
+3,622
+3% +$33.2K ﹤0.01% 3041
2025
Q4
$1.27M Sell
132,700
-21,100
-14% -$215K ﹤0.01% 3102
2025
Q3
$1.5M Buy
153,800
+5,450
+4% +$41.9K ﹤0.01% 2972
2025
Q2
$900K Buy
148,350
+2,341
+2% +$17.6K ﹤0.01% 3185
2025
Q1
$1.81M Sell
146,009
-4,229
-3% -$59.8K ﹤0.01% 2746
2024
Q4
$2.08M Buy
150,238
+19,452
+15% +$307K ﹤0.01% 2749
2024
Q3
$2.19M Sell
130,786
-34,637
-21% -$745K ﹤0.01% 2704
2024
Q2
$3.41M Buy
165,423
+19,578
+13% +$424K ﹤0.01% 2518
2024
Q1
$3.61M Sell
145,845
-296,464
-67% -$8.82M ﹤0.01% 2476
2023
Q4
$16.1M Sell
442,309
-57,073
-11% -$2.2M ﹤0.01% 1706
2023
Q3
$24.1M Sell
499,382
-14,851
-3% -$882K 0.01% 1454
2023
Q2
$35.1M Buy
514,233
+350,141
+213% +$22.6M 0.01% 1224
2023
Q1
$7.95M Buy
164,092
+27,095
+20% +$1.43M ﹤0.01% 2042
2022
Q4
$8.25M Sell
136,997
-3,195
-2% -$187K ﹤0.01% 2036
2022
Q3
$8.5M Buy
140,192
+20,828
+17% +$658K ﹤0.01% 1993
2022
Q2
$3.24M Sell
119,364
-34,917
-23% -$1.02M ﹤0.01% 2553
2022
Q1
$5.64M Buy
154,281
+1,821
+1% +$65.6K ﹤0.01% 2358
2021
Q4
$7.53M Buy
152,460
+15,173
+11% +$841K ﹤0.01% 2255
2021
Q3
$9.78M Buy
137,287
+1,832
+1% +$114K ﹤0.01% 2135
2021
Q2
$6.96M Buy
135,455
+5,455
+4% +$170K ﹤0.01% 2331
2021
Q1
$3.27M Sell
130,000
-9,522
-7% -$179K ﹤0.01% 2650
2020
Q4
$1.68M Sell
139,522
-9,160
-6% -$108K ﹤0.01% 2949
2020
Q3
$1.49M Sell
148,682
-10,867
-7% -$131K ﹤0.01% 2864
2020
Q2
$1.67M Sell
159,549
-172,891
-52% -$1.92M ﹤0.01% 2786
2020
Q1
$3.56M Sell
332,440
-4,072
-1% -$49.3K ﹤0.01% 2253
2019
Q4
$5.33M Buy
336,512
+2,683
+0.8% +$28.8K ﹤0.01% 2308
2019
Q3
$2.62M Sell
333,829
-5,483
-2% -$48.7K ﹤0.01% 2605
2019
Q2
$3.59M Sell
339,312
-22,176
-6% -$228K ﹤0.01% 2495
2019
Q1
$4.38M Sell
361,488
-11,584
-3% -$145K ﹤0.01% 2398
2018
Q4
$3.84M Buy
373,072
+169,070
+83% +$2.01M ﹤0.01% 2439
2018
Q3
$2.67M Buy
204,002
+15,907
+8% +$230K ﹤0.01% 2693
2018
Q2
$2.74M Buy
188,095
+8,842
+5% +$175K ﹤0.01% 2678
2018
Q1
$6.58M Buy
179,253
+3,405
+2% +$124K ﹤0.01% 2203
2017
Q4
$6.59M Sell
175,848
-9,572
-5% -$487K ﹤0.01% 2216
2017
Q3
$12M Sell
185,420
-42
-0% -$2.57K ﹤0.01% 1892
2017
Q2
$10M Buy
185,462
+13,492
+8% +$719K ﹤0.01% 1970
2017
Q1
$9.59M Buy
171,970
+10,397
+6% +$546K ﹤0.01% 1999
2016
Q4
$7.95M Buy
161,573
+1,629
+1% +$89.9K ﹤0.01% 2077
2016
Q3
$9.59M Sell
159,944
-2,726
-2% -$146K ﹤0.01% 1899
2016
Q2
$5.69M Buy
162,670
+1,917
+1% +$83.5K ﹤0.01% 2147
2016
Q1
$6.62M Sell
160,753
-2,184
-1% -$85.5K ﹤0.01% 2041
2015
Q4
$11.1M Sell
162,937
-2,867
-2% -$173K ﹤0.01% 1777
2015
Q3
$7.52M Sell
165,804
-27,096
-14% -$1.58M ﹤0.01% 2011
2015
Q2
$10.2M Buy
192,900
+41,115
+27% +$1.62M ﹤0.01% 1959
2015
Q1
$5.79M Buy
151,785
+12,347
+9% +$317K ﹤0.01% 2235
2014
Q4
$2.9M Buy
139,438
+15,140
+12% +$316K ﹤0.01% 2616
2014
Q3
$2.75M Buy
124,298
+26,857
+28% +$569K ﹤0.01% 2658
2014
Q2
$2.2M Buy
97,441
+11,604
+14% +$290K ﹤0.01% 2857
2014
Q1
$3.29M Buy
85,837
+13,866
+19% +$447K ﹤0.01% 2560
2013
Q4
$1.91M Buy
71,971
+18,104
+34% +$454K ﹤0.01% 2917
2013
Q3
$1.09M Buy
53,867
+5,032
+10% +$89K ﹤0.01% 3196
2013
Q2
$631K Buy
+48,835
New +$454K ﹤0.01% 3408

Other funds holding PRTA

Bank of New York Mellon's PRTA Position: Q2 2026 in Review

Bank of New York Mellon reduced its Prothena Corp (PRTA) stake by 1.8% in Q2 2026, selling an estimated $23.9K and leaving 133,906 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Bank of New York Mellon first reported a position in PRTA in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.1M in Q2 2023. 76 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Bank of New York Mellon held 133,906 shares of Prothena Corp worth $1.31M as of Q2 2026.
  • Bank of New York Mellon sold 2,416 Prothena Corp shares in Q2 2026, an estimated $23.9K.
  • Prothena Corp made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3207 holding.
  • Bank of New York Mellon first reported a position in Prothena Corp in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Prothena Corp position peaked at $35.1M in Q2 2023.
  • 76 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.